Abstract
Long known for its anti-nociceptive effects, the opioid β-endorphin is also reported to have rewarding and reinforcing properties and to be involved in stress response. In this manuscript we summarize the present neurobiological and behavioral evidence regarding the role of β-endorphin in stress-related psychiatric disorders, depression and PTSD. There is existing data that support the importance of β-endorphin neurotransmission in mediating depression. As for PTSD, however, the data is thus far circumstantial. The studies described herein used diverse techniques, such as biochemical measurements of β-endorphin in various brain sites and behavioral monitoring, in two animal models of depression and PTSD. We suggest that the pathways for stress-related psychiatric disorders, depression and PTSD, converge to a common pathway in which β-endorphin is a modulating element of distress. This may occur its interaction with the mesolimbic monoaminergic system and also by its interesting effects on learning and memory. The possible involvement of β- endorphin in the process of stress-related psychiatric disorders, depression and PTSD, is discussed.
Keywords: Anxiety, depression, post-traumatic stress disorder (PTSD), opioids
Current Drug Targets
Title: The β-Endorphin Role in Stress-Related Psychiatric Disorders
Volume: 10 Issue: 11
Author(s): Avia Merenlender-Wagner, Yahav Dikshtein and Gal Yadid
Affiliation:
- Leslie and Susan Gonda (Goldschmied) Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat-Gan 52900, ISRAEL.,Israel
Keywords: Anxiety, depression, post-traumatic stress disorder (PTSD), opioids
Abstract: Long known for its anti-nociceptive effects, the opioid β-endorphin is also reported to have rewarding and reinforcing properties and to be involved in stress response. In this manuscript we summarize the present neurobiological and behavioral evidence regarding the role of β-endorphin in stress-related psychiatric disorders, depression and PTSD. There is existing data that support the importance of β-endorphin neurotransmission in mediating depression. As for PTSD, however, the data is thus far circumstantial. The studies described herein used diverse techniques, such as biochemical measurements of β-endorphin in various brain sites and behavioral monitoring, in two animal models of depression and PTSD. We suggest that the pathways for stress-related psychiatric disorders, depression and PTSD, converge to a common pathway in which β-endorphin is a modulating element of distress. This may occur its interaction with the mesolimbic monoaminergic system and also by its interesting effects on learning and memory. The possible involvement of β- endorphin in the process of stress-related psychiatric disorders, depression and PTSD, is discussed.
Export Options
About this article
Cite this article as:
Merenlender-Wagner Avia, Dikshtein Yahav and Yadid Gal, The β-Endorphin Role in Stress-Related Psychiatric Disorders, Current Drug Targets 2009; 10(11) . https://dx.doi.org/10.2174/138945009789735147
DOI https://dx.doi.org/10.2174/138945009789735147 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Association of EGF rs4444903 and XPD rs13181 Polymorphisms with Cutaneous Melanoma in Caucasians
Medicinal Chemistry Protein Amyloidogenesis Investigated by Small Angle Scattering
Current Pharmaceutical Design Factors of Rapid Cognitive Decline in Late Onset Alzheimer's Disease
Current Aging Science The Computational Analysis Conducted on miRNA Target Sites in Association with SNPs at 3’UTR of ADHD-implicated Genes
Central Nervous System Agents in Medicinal Chemistry Editorial - A Milestone for Current Alzheimer Research [Hot Topic: Neurogenesis Catalyst Conference (Guest Editors: Howard M. Fillit & Gunnar Gouras) ]
Current Alzheimer Research 5'-Nucleotidases, Nucleosides and their Distribution in the Brain: Pathological and Therapeutic Implications
Current Medicinal Chemistry Purinergic Signaling and Energy Homeostasis in Psychiatric Disorders
Current Molecular Medicine Immunomodulatory Strategies for Huntington's Disease Treatment
CNS & Neurological Disorders - Drug Targets Age-related Changes in Pharmacodynamics: Focus on Drugs Acting on Central Nervous and Cardiovascular Systems
Current Drug Metabolism The Role of Omega-3 Polyunsaturated Fatty Acids Supplementation in Childhood: A Review
Recent Patents on Cardiovascular Drug Discovery First Episode Psychosis, Substance Abuse and Prognosis: A Systematic Review
Current Psychiatry Reviews Unraveling the Action Mechanism of Buyang Huanwu Tang (BYHWT) for Cerebral Ischemia by Systematic Pharmacological Methodology
Combinatorial Chemistry & High Throughput Screening Insight into the Epigenetics of Alzheimer's Disease: A Computational Study from Human Interactome
Current Alzheimer Research p-Benzoquinone as a Privileged Scaffold of Pharmacological Significance: A Review
Mini-Reviews in Medicinal Chemistry Treatment Considerations in the Forensic Patient with Schizophrenia
Current Pharmaceutical Design Nur77 Family of Nuclear Hormone Receptors
Current Drug Targets - Inflammation & Allergy Mitochondrial VDAC1: Function in Cell Life and Death and a Target for Cancer Therapy
Current Medicinal Chemistry Rectifying Attenuated Store-Operated Calcium Entry as a Therapeutic Approach for Alzheimer’s Disease
Current Alzheimer Research Positive Emotional Learning Induces Resilience to Depression: A Role for NMDA Receptor-mediated Synaptic Plasticity
Current Neuropharmacology “Epileptic Encephalopathy” of Infancy and Childhood: Electro-Clinical Pictures and Recent Understandings
Current Neuropharmacology